BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, Raimondo MG, Tur C, Wirsching A, Wacker J, Düsing C, Distler JH, Kuwert T, Bozec A, Ramming A, Schett G, Grieshaber Bouyer R (2024)
Publication Type: Journal article, Letter
Publication year: 2024
Journal
Book Volume: 391
Pages Range: 867-869
Journal Issue: 9
DOI: 10.1056/NEJMc2408786
Authors with CRIS profile
Melanie Hagen
Department of Medicine 3 – Rheumatology and Immunology
Laura Bucci
Department of Medicine 3 – Rheumatology and Immunology
Sebastian Böltz
Department of Medicine 3 – Rheumatology and Immunology
Danae-Mona Nöthling
Lehrstuhl für Mikrobiologie und Infektionsimmunologie
Tobias Rothe
Department of Medicine 3 – Rheumatology and Immunology
Kirill Anoshkin
Department of Medicine 3 – Rheumatology and Immunology
Maria Gabriella Raimondo
Department of Medicine 3 – Rheumatology and Immunology
Carlo Tur
Department of Medicine 3 – Rheumatology and Immunology
Torsten Kuwert
Lehrstuhl für Klinische Nuklearmedizin
Aline Bozec
Professur für Experimentelle Immuntherapie
Andreas Ramming
Professur für Immunologie der Organschädigung
Georg Schett
Lehrstuhl für Innere Medizin III
Ricardo Grieshaber Bouyer
Professur für Klinische Systemimmunologie
Involved external institutions
Germany (DE)How to cite
APA:
Hagen, M., Bucci, L., Böltz, S., Nöthling, D.-M., Rothe, T., Anoshkin, K.,... Grieshaber Bouyer, R. (2024). BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease. New England Journal of Medicine, 391(9), 867-869. https://doi.org/10.1056/NEJMc2408786
MLA:
Hagen, Melanie, et al. "BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease." New England Journal of Medicine 391.9 (2024): 867-869.
BibTeX: Download